On April 21, 2022, Andrey Dyadyura was appointed CEO of Exacte Labs.
Vasily Kazey, will continue to work on the development of the Exacte Labs as an advisor to the general director.
Nadezhda Lifantseva was appointed to the position of Deputy CEO for Technology.
Within Exacte Labs, a scientific and technical council was created consisting of V.I. Kazey, N.V. Lifantseva, D.Yu. Grebenkin, P.D. Sobolev and B.A. Krapivkin.
Changes in the company's management team are aimed at strengthening the management team and reflect Exacte Labs' commitment to improving the reliability and efficiency of the business and providing partners with exceptional service and all bioanalytical laboratory services required by pharmaceutical companies.
Commenting on his appointment, Andrey Dyadyura said: "The new position is a big job and high responsibility. In the current economic situation it is a challenge, despite the fact that the pharmaceutical market in Russia is developing dynamically and domestic and foreign pharmaceutical companies continue to develop new drugs. Exacte Labs' team of professionals is ready to provide a platform for clinical trials, pharmaceutical analysis and bioequivalence studies, exceptional service and reliable partnership".